Extracellular Vesicle (EV) Immunophenotyping Service
Background Service Workflow Advantages FAQs Related Sections Contact Us
Creative Biolabs offers a specialized extracellular vesicle (EV) immunophenotyping service designed to tackle critical challenges in biochemistry and biopharmaceutical development. Our service provides a cost-effective solution to accelerate drug discovery, ensure the production of high-quality recombinant proteins, facilitate the development of highly specific antibodies, and streamline complex clinical trials. We achieve this through the application of cutting-edge technologies, including advanced recombinant DNA techniques, high-throughput screening platforms, and innovative protein engineering methodologies.
The Critical Need for EV Immunophenotyping
Extracellular vesicles (EVs) are pivotal mediators of intercellular communication, playing significant roles in both physiological and pathological processes. Their unique cargo and surface protein profiles make them invaluable as potential biomarkers for disease diagnosis and prognosis, and as natural nanocarriers for targeted therapeutic delivery. The precise characterization of EV surface markers, known as immunophenotyping, is essential for understanding their biological functions and harnessing their therapeutic potential. Given the inherent heterogeneity and nanoscale dimensions of EVs, robust and highly sensitive immunophenotyping methods are critically needed to accurately identify specific EV subpopulations and ensure quality control in clinical applications.
Fig.1 EV biogenesis and variability.1
Extracellular Vesicle (EV) Immunophenotyping Service at Creative Biolabs
Creative Biolabs' extracellular vesicle (EV) immunophenotyping service offers precise and comprehensive characterization of EV surface markers, providing critical insights for your research and development projects. We deliver detailed profiles of EV populations, enabling the identification of specific biomarkers, validation of therapeutic targets, and optimization of EV-based drug delivery systems. Our service is designed to overcome the challenges associated with EV analysis, ensuring reliable and reproducible results that accelerate your progress.
Required Starting Materials
-
Isolated EV Samples: Purified extracellular vesicle samples derived from various biological sources (e.g., cell culture supernatant, plasma, serum, urine, cerebrospinal fluid).
-
Relevant Biological Information: Detailed information about the source cells/tissue, experimental conditions, and specific research objectives to guide antibody panel selection.
-
Targeted Antibody Information (Optional): If specific EV surface markers are of interest, providing information on desired antibodies can expedite the process.
Workflow
Step 1: Sample Quality Assessment & Preparation
Upon receipt, EV samples undergo rigorous quality control to assess purity and concentration. Samples are then carefully prepared for downstream immunophenotyping, which may involve concentration or buffer exchange.
Step 2: EV Capture & Antibody Incubation
EVs are captured onto specialized beads to facilitate their detection and analysis. The captured EVs are then incubated with a carefully selected panel of fluorescently labeled antibodies targeting specific surface proteins. This step ensures the precise binding of antibodies to their respective EV markers.
Step 3: Flow Cytometry Analysis
The antibody-labeled EV-bead complexes are analyzed using state-of-the-art flow cytometry. This high-throughput technique allows for the simultaneous detection and quantification of multiple surface markers on individual EVs, providing a comprehensive immunophenotypic profile.
Step 4: Data Acquisition & Preliminary Processing
Raw data is acquired from the flow cytometer, capturing events for each EV-bead complex. Preliminary data processing involves gating strategies to identify and isolate EV-positive events and remove background noise.
Step 5: Advanced Bioinformatic Analysis
The processed flow cytometry data undergoes in-depth bioinformatic analysis. This includes statistical analysis, clustering, and visualization techniques to identify distinct EV subpopulations, quantify marker expression levels, and uncover correlations with experimental variables.
Step 6: Quality Assurance & Validation
Throughout the entire workflow, stringent quality control measures are implemented. This includes positive and negative controls, instrument calibration, and replicate analyses to ensure the accuracy, reproducibility, and reliability of the immunophenotyping results.
Our Service Highlights
-
High Sensitivity: Detect even low-abundance EV populations and markers.
-
Multiplexing Capability: Simultaneously analyze multiple surface markers on a single EV.
-
Robust & Reproducible Results: Benefit from our standardized protocols and rigorous quality control.
-
Comprehensive Data: Gain deep insights into EV heterogeneity and biological function.
-
Accelerated Research: Obtain critical data quickly to advance your projects.
FAQs
Q1: What types of samples can be used for EV immunophenotyping?
A1: We can perform EV immunophenotyping on a wide range of biological samples, including isolated EVs from cell culture supernatants, plasma, serum, urine, cerebrospinal fluid, and other biofluids. Please contact us to discuss your specific sample type.
Q2: How many EV surface markers can be analyzed simultaneously?
A2: Our advanced bead-based flow cytometry platform allows for the simultaneous analysis of multiple EV surface markers, enabling comprehensive multiplexed immunophenotyping. The exact number depends on the specific antibody panel and experimental design.
Q3: What is the typical turnaround time for the EV immunophenotyping service?
A3: The estimated timeframe for our service typically ranges from 4 to 8 weeks, depending on the project's complexity and the number of samples. We strive to deliver high-quality results efficiently.
Q4: How does Creative Biolabs ensure the quality and accuracy of the results?
A4: We implement stringent quality control measures at every stage of the workflow, from sample preparation and antibody validation to data acquisition and analysis. This includes positive and negative controls, instrument calibration, and replicate analyses to ensure the highest level of accuracy and reproducibility.
Q5: Can your service help with identifying novel EV biomarkers for disease diagnosis?
A5: Absolutely. Our comprehensive EV immunophenotyping service is an ideal tool for biomarker discovery. By providing detailed profiles of EV surface proteins, we can help you identify and validate novel EV-based biomarkers for various diseases and conditions.
Related Sections
Beyond this service, Creative Biolabs also offers complementary services crucial for advancing nanomedicine development.
Why Choose Creative Biolabs
Creative Biolabs is your premier partner for extracellular vesicle Immunophenotyping. Leveraging our extensive experience and advanced technology, we deliver the precise, high-quality data essential for accelerating your drug discovery, biomarker identification, and therapeutic development. Our commitment is to provide solutions that overcome complex challenges and drive scientific breakthroughs. If you're looking to accurately immunophenotype your extracellular vesicles, reach out to us today.
Reference
-
Lee, Yoon-Jin et al. "Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy." Frontiers in oncology vol. 13 1256585. 26 Sep. 2023, doi:10.3389/fonc.2023.1256585. Distributed under Open Access License CC BY 4.0, without modification.
